An Evaluation of the Correlation between Hepcidin Serum Levels and Disease Activity in Inflammatory Bowel Disease
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Aim. While there are many well-defined serological markers for inflammatory bowel disease (IBD), there is limited evidence that they positively affect clinical outcomes. This study aimed to evaluate the correlation between hepcidin serum levels and disease activity in IBD.Materials and Methods. Eighty-five consecutive IBD patients were enrolled in the study. Hepcidin serum levels were assessed using an enzyme-linked immunosorbent assay (ELISA) and were compared with disease activity as well as the interleukin-6 (IL-6) and C-reactive protein (CRP) levels.Results. The mean hepcidin serum levels in Crohn’s disease (CD) patients in remission and in the active phase were3837±1436and3752±1274 pg/mL, respectivelyP=0.613. The mean hepcidin serum levels in ulcerative colitis (UC) patients in remission and in the active phase were4285±8623and3727±1176 pg/mL, respectivelyP=0.241. Correlation analysis between inflammatory markers and hepcidin serum levels indicated that there was no correlation between hepcidin levels and IL-6P=0.582or CRPP=0.783.Conclusion. As an acute-phase protein, hepcidin seems to have a lower efficacy than other parameters in the detection of activation in IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Furthermore, in almost all patient cohorts, HAMP concentration positively correlates with disease activity linking the extent of inflammation to the severity of iron sequestration in the MPS [37–43].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [39]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J.-F., Gasche, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,409
Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712243172603 · Cited by 3,026
D’Haens, G., Sandborn, W. J., Feagan, B. G., Geboes, K., Hanauer, S. B., Irvine, E. J., Lémann, M., Marteau, P., Rutgeerts, P., Schölmerich, J., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.12.038 · Cited by 1,207
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026
Interleukin-6 induces hepcidin expression through STAT3
Wrighting, D. M., & Andrews, N. C. (2006) · Blood · doi:10.1182/blood-2006-06-027631 · Cited by 983 · cited 1×
“The hepcidin levels increase during inflammation primarily as a result of increased “bone morphogenetic protein-6” (BMP-6) and interleukin-6 (IL-6) levels [4, 5].”
BackgroundDiagnosis and management of iron deficiency anemia in patients with IBD
Stein, J., Hartmann, F., & Dignass, A. U. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.151 · Cited by 304
Zhao, N., Zhang, A.-S., & Enns, C. A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67225 · Cited by 209
Semrin, G., Fishman, D. S., Bousvaros, A., Zholudev, A., Saunders, A. C., Correia, C. E., Nemeth, E., Grand, R. J., & Weinstein, D. A. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000235097.86360.04 · Cited by 182
Role of Hepcidin in the Setting of Hypoferremia during Acute Inflammation
Deschemin, J.-C., & Vaulont, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061050 · Cited by 89 · cited 1×
“Hepcidin plays a crucial role in the pathogenesis of chronic disease-related anaemia which is also called inflammation-related anaemia [3].”
BackgroundHepcidin is a key mediator of anemia of inflammation in Crohn's disease
Basseri, R. J., Nemeth, E., Vassilaki, M. E., Basseri, B., Enayati, P., Shaye, O., Bourikas, L. A., Ganz, T., & Papadakis, K. A. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.10.013 · Cited by 81
Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease
Oustamanolakis, P., Koutroubakis, I. E., Messaritakis, I., Malliaraki, N., Sfiridaki, A., & Kouroumalis, E. A. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328343b885 · Cited by 77
ABDEL-KHALEK, M. A., EL-BARBARY, A. M., ESSA, S. A.-M., & GHOBASHI, A. S. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110339 · Cited by 68
The bone morphogenetic protein–hepcidin axis as a therapeutic target in inflammatory bowel disease
Wang, L., Trebicka, E., Fu, Y., Ellenbogen, S., Hong, C. C., Babitt, J. L., Lin, H. Y., & Cherayil, B. J. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21675 · Cited by 64
Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis
Arnold, J., Sangwaiya, A., Bhatkal, B., Geoghegan, F., & Busbridge, M. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32830e2885 · Cited by 53
Arabul, M., Çelık, M., Aslan, O., Torun, S., Beyazıt, Y., Alper, E., Kandemır, A., & Ünsal, B. (2013) · PubMed · doi:10.5754/hge12770 · Cited by 27
Self-citationSerum prohepcidin levels in chronic inflammatory bowel diseases
Nagy, J., Lakner, L., Poór, V. S., Pandur, E., Mózsik, G., Miseta, A., & Sipos, K. (2010) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2010.07.010 · Cited by 20
Cited by
Nairz, M., Theurl, I., Wolf, D., & Weiss, G. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0505-7 · Cited by 152
Tran, D. H.-N., Wang, J., Ha, C. Y., Ho, W. W., Mattai, S. A., Oikonomopoulos, A., Weiss, G. A., Lacey, P. N., Cheng, M., Shieh, C., et al. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0619-4 · Cited by 55
The Effects of Iron Supplementation and Fortification on the Gut Microbiota: A Review
Finlayson-Trick, E. C., Fischer, J. A. J., Goldfarb, D. A., & Karakochuk, C. D. (2020) · Gastrointestinal Disorders · doi:10.3390/gidisord2040030 · Cited by 37
Cavallaro, F., Duca, L., Pisani, L. F., Rigolini, R., Spina, L., Tontini, G. E., Munizio, N., Costa, E., Cappellini, M. D., Vecchi, M. L., et al. (2017) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2017/6843976 · Cited by 34
Loveikyte, R., Bourgonje, A. R., van der Reijden, J. J., Bulthuis, M. L. C., Hawinkels, L. J. A. C., Visschedijk, M. C., Festen, E. A. M., van Dullemen, H. M., Weersma, R. K., van Goor, H., et al. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad010 · Cited by 27
Metadata
- Authors
- Paköz, Z. B., Çekiç, C., Arabul, M., Sarıtaş Yüksel, E., İpek, S., Vatansever, S., & Ünsal, B.
- Affiliations
- Izmir Kâtip Çelebi University (TR)
- Department of Gastroenterology, Izmir Katip Çelebi University, İzmir Atatürk Eğitim ve Araştırma Hastanesi, Karabağlar, 35160 İzmir, Turkey
- Corresponding author
- Çekiç, Cem
- Venue
- Gastroenterology Research and Practice
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-4
- ISSN
- 1687-6121 (ISSN-L)
- 1687-630X
- PMC
- PMC4299302
- OpenAlex
- W2046291329
- Cited by
- 26
- References
- 16
- Citations by year
- 2024: 2 · 2023: 5 · 2022: 3 · 2021: 2 · 2020: 3 · 2018: 2 · 2017: 4 · 2016: 5
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Gastroenterology Research and Practice (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- hepcidin, inflammatory bowel disease, disease activity, Crohn's disease, ulcerative colitis, interleukin-6, C-reactive protein, acute phase proteins, serological markers, remission
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
